go back

Lung Cancer Outlook Signature Test

Rhode Island rates for HCPCS 81538

A specialized laboratory test used in advanced lung cancer that measures a set of markers in a patient sample and combines them into a single result placing the person in a better or poorer outlook group. The result is used to help judge which type of treatment is most likely to benefit them.

Rates data updated July 2026.

Facilitymedian $3,715 · 10th–90th $2,138$16,5960%20%10th90th$3,715Professionalmedian $1,585 · 10th–90th $1,479$2,5700%20%10th90th$1,585$1.0K$2.0K$5.0K$10.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$6,165.95
Median
$9,549.93
Typical High
$16,595.87
Aetna
Setting
Professional
Modifier
Global
Typical Low
$1,479.11
Median
$1,479.11
Typical High
$1,584.89
BCBS
Setting
Facility
Modifier
Global
Typical Low
$1,905.46
Median
$3,311.31
Typical High
$3,467.37
BCBS
Setting
Professional
Modifier
Global
Typical Low
$2,137.96
Median
$2,137.96
Typical High
$2,137.96
Cigna
Setting
Facility
Modifier
Global
Typical Low
$3,715.35
Median
$6,456.54
Typical High
$7,943.28
Cigna
Setting
Professional
Modifier
Global
Typical Low
$1,202.26
Median
$1,698.24
Typical High
$3,890.45
United
Setting
Facility
Modifier
Global
Typical Low
$2,951.21
Median
$3,467.37
Typical High
$3,467.37
United
Setting
Professional
Modifier
Global
Typical Low
$1,071.52
Median
$1,737.80
Typical High
$3,090.30